Scientific Opinion on the substantiation of health claims related to coffee, including chlorogenic acids from coffee, and protection of DNA, proteins and lipids from oxidative damage (ID 1099, 3152, 4301), maintenance of normal blood glucose concentrations (ID 1100, 1962), and contribution to the maintenance or achievement of a normal body weight (ID 2031, 4326) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

EFSA Journal

Volumn 9, Issue 4, 2011, Pages

[No Author Info available]

Author keywords

blood glucose; Coffee; health claims; oxidative damage; weight management

Indexed keywords

EID: 85078371917     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2011.2057     Document Type: Article

References (29)

1. Bandyopadhyay G, Biswas T, Roy KC, Mandal S, Mandal C, Pal BC, Bhattacharya S, Rakshit S, Bhattacharya DK, Chaudhuri U, Konar A and Bandyopadhyay S, 2004. Chlorogenic acid inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-activated protein kinase-dependent apoptosis in chronic myelogenous leukemic cells. Blood, 104, 2514–2522.
2. Battram DS, Arthur R, Weekes A and Graham TE, 2006. The glucose intolerance induced by caffeinated coffee ingestion is less pronounced than that due to alkaloid caffeine in men. Journal of Nutrition, 136, 1276–1280.
3. Bichler J, Cavin C, Simic T, Chakraborty A, Ferk F, Hoelzl C, Schulte-Hermann R, Kundi M, Haidinger G, Angelis K and Knasmuller S, 2007. Coffee consumption protects human lymphocytes against oxidative and 3-amino-1-methyl-5H-pyrido[4,3-b]indole acetate (Trp-P-2) induced DNA-damage: results of an experimental study with human volunteers. Food and Chemical Toxicology, 45, 1428–1436.
4. Bidel S, Hu G, Sundvall J, Kaprio J and Tuomilehto J, 2006. Effects of coffee consumption on glucose tolerance, serum glucose and insulin levels-a cross-sectional analysis. Hormone and Metabolic Research, 38, 38–43.
5. Dalle-Donne I, Rossi R, Colombo R, Giustarini D and Milzani A, 2006. Biomarkers of oxidative damage in human disease. Clinical Chemistry, 52, 601–623.
6. Dellalibera O, Lemaire B and Lafay S, 2006. Svetol®, green coffee extract, induces weight loss and increases lean to fat ratio in volunteers with overweight problems. Phytotherapie, 4, 1–4.
7. Dragsted L, 2008. Biomarkers of exposure to vitamins A, C, and E and their relation to lipid and protein oxidation markers. European Journal of Nutrition, 47, Suppl 2, 3–18.
8. Dusinska M and Collins A, 2008. The comet assay in human biomonitoring: gene-environment interactions. Mutagenesis, 23, 191–205.
9. Esposito F, Morisco F, Verde V, Ritieni A, Alezio A, Caporaso N and Fogliano V, 2003. Moderate coffee consumption increases plasma glutathione but not homocysteine in healthy subjects. Alimentary Pharmacology and Therapeutics, 17, 595–601.
10. Feinberg L, Sandberg H, De Castro O and Bellet S, 1968. Effects of coffee consumption on oral glucose tolerance curves in normal human subjects. Metabolism: Clinical and Experimental, 17, 916–922.
11. Feng R, Lu Y, Bowman LL, Qian Y, Castranova V and Ding M, 2005. Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. Journal of Biological Chemistry, 280, 27888–27895.
12. Griffiths H, Moller L, Bartosz G, Bast A, Bertoni-Freddari C, Collins A, Cooke M, Coolen S, Haenen G, Hoberg A, Loft S, Lunec J, Olinski R, Parry J, Pompella A, Poulsen H, Verhagen H and Astley S, 2002. Biomarkers. Molecular Aspects of Medicine, 23, 101–208.
13. Grubben MJ, Van Den Braak CC, Broekhuizen R, De Jong R, Van Rijt L, De Ruijter E, Peters WH, Katan MB and Nagengast FM, 2000. The effect of unfiltered coffee on potential biomarkers for colonic cancer risk in healthy volunteers: a randomized trial. Alimentary Pharmacology and Therapeutics, 14, 1181–1190.
14. Johnston KL, Clifford MN and Morgan LM, 2003. Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. American Journal of Clinical Nutrition, 78, 728–733.
15. Keijzers GB, De Galan BE, Tack CJ and Smits P, 2002. Caffeine can decrease insulin sensitivity in humans. Diabetes Care, 25, 364.
16. Knasmuller S, Nersesyan A, Misik M, Gerner C, Mikulits W, Ehrlich V, Hoelzl C, Szakmary A and Wagner KH, 2008. Use of conventional and -omics based methods for health claims of dietary antioxidants: a critical overview. British Journal of Nutrition, 99 E Suppl 1E, S3–52.
17. Lee KJ and Jeong HG, 2007. Protective effects of kahweol and cafestol against hydrogen peroxide-induced oxidative stress and DNA damage. Toxicology Letters, 173, 80–87.
18. Mayne S, 2003. Antioxidant nutrients and chronic disease: use of biomarkers of exposure and oxidative stress status in epidemiologic research. Journal of Nutrition, 133 Suppl 3, 933S–940S.
19. Mursu J, Voutilainen S, Nurmi T, Alfthan G, Virtanen JK, Rissanen TH, Happonen P, Nyyssonen K, Kaikkonen J, Salonen R and Salonen JT, 2005. The effects of coffee consumption on lipid peroxidation and plasma total homocysteine concentrations: a clinical trial. Free Radical Biology and Medicine, 38, 527–534.
20. Naismith DJ, Akinyanju PA, Szanto S and Yudkin J, 1970. The effect, in volunteers, of coffee and decaffeinated coffee on blood glucose, insulin, plasma lipids and some factors involved in blood clotting. Nutrition and Metabolism, 12, 144–151.
21. Nardini M, D'Aquino M, Tomassi G, Gentili V, Di Felice M and Scaccini C, 1995. Inhibition of human low-density lipoprotein oxidation by caffeic acid and other hydroxycinnamic acid derivatives. Free Radical Biology and Medicine, 19, 541–552.
22. Nardini M, Natella F, Gentili V, Di Felice M and Scaccini C, 1997. Effect of caffeic acid dietary supplementation on the antioxidant defense system in rat: an in vivo study. Archives of Biochemistry and Biophysics, 342, 157–160.
23. Natella F, Nardini M, Giannetti I, Dattilo C and Scaccini C, 2002. Coffee drinking influences plasma antioxidant capacity in humans. Journal of Agricultural and Food Chemistry, 50, 6211–6216.
24. Richelle M, Tavazzi I and Offord E, 2001. Comparison of the antioxidant activity of commonly consumed polyphenolic beverages (coffee, cocoa, and tea) prepared per cup serving. Journal of Agricultural and Food Chemistry, 49, 3438–3442.
25. Steinkellner H, Hoelzl C, Uhl M, Cavin C, Haidinger G, Gsur A, Schmid R, Kundi M, Bichler J and Knasmuller S, 2005. Coffee consumption induces GSTP in plasma and protects lymphocytes against (+/-)-anti-benzo[a]pyrene-7, 8-dihydrodiol-9, 10-epoxide induced DNA-damage: results of controlled human intervention trials. Mutation Research, 591, 264–275.
26. Thom E, 2007. The effect of chlorogenic acid enriched coffee on glucose absorption in healthy volunteers and its effect on body mass when used long-term in overweight and obese people. Journal of International Medical Research, 35, 900–908.
27. van Dam RM, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM and Heine RJ, 2004. Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study. Diabetologia, 47, 2152–2159.
28. Wu T, Willett WC, Hankinson SE and Giovannucci E, 2005. Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in U.S. women. Diabetes Care, 28, 1390–1396.
29. Yukawa GS, Mune M, Otani H, Tone Y, Liang XM, Iwahashi H and Sakamoto W, 2004. Effects of coffee consumption on oxidative susceptibility of low-density lipoproteins and serum lipid levels in humans. Biochemistry, 69, 70–74.